High materiality7/10
Axsome Therapeutics price target raised to $275 from $260 at Guggenheim
Why it may matterVerify against the original reporting
Upside potential from upgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises AXSM PT to $275 from $260. Current price $220.89. Implied upside ~24% to target.
- Guggenheim raises PT to $275 from $260.
- Current price $220.89.
- Implied upside ~24%.
Key facts
- 01
Target: $275
- 02
Posted price: $220.89
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.